Journals / Medicine Science / 2019 / Cilt: 8 - Sayı: 1

Does heparin dosage calculated with ideal body weight reduce blood product use in open heart surgery?

Pages
123–128
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Heparin and protamine doses decreased, while postoperative bleeding, transfusion requirements and hospitalization decreased.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The heparin regimen providing anticoagulation during cardiopulmonary bypass (CPB) is usually adapted to total body weight (TBW).
📊
Key Findings & Data:However, this may cause redundant anticoagulation and increase perioperative bleeding, transfusion requirements and reoperation.
💡
Conclusion & Impact:Heparin and protamine doses decreased, while postoperative bleeding, transfusion requirements and hospitalization decreased.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

The heparin regimen providing anticoagulation during cardiopulmonary bypass (CPB) is usually adapted to total body weight (TBW). However, this may cause redundant anticoagulation and increase perioperative bleeding, transfusion requirements and reoperation. We compared a heparin regimen based on ideal body weight (IBW) with the traditional regimen. After ethical approval, 100 adults undergoing elective cardiac surgery with CPB were recruited for the prospective, observational study in a tertiary hospital. Prior to CBP an unfractioned heparin dose was adjusted to 300 IU/kg based on TBW (Group TBW, n=50), or IBW (Group IBW, n=50). IBW was calculated using the Lorentz formula. The minimal Activated Coagulation Time (ACT) target value is 400 sec for CPB. Demographic data, cross-clamp and CPB durations, and Hb, Htc, platelet, PT, Aptt and fibrinogen values were similar between the groups (p>0.05). Heparin and total protamine doses were significantly higher in Group IBW (p<0.001). Differences were also determined in ACT-1, ACT-2, and ACT-3 (p˂0.05). Group TBW had significantly higher ACT values after initial heparin doses (p=0.02) and Group IBW after reversal with protamine (p=0.001). Amounts of blood and blood products used differed significantly (p<0.001). In terms of drainage at 6 and 24 h, blood loss was significantly higher in Group TBW (p<0.001). Postoperative erythrocyte suspension and fresh frozen plasma use were higher in Group TBW (p<0.001), and length of ICU stay was significantly longer (p<0.006). Heparin doses based on IBW provided sufficient anticoagulation. Heparin and protamine doses decreased, while postoperative bleeding, transfusion requirements and hospitalization decreased.

🔖

Cite This Article

KARA, D., SARIKAŞ, C. M., DEMİR, A., KAYĞIN, M. A., ÜNAL, E. U. (2019). Does heparin dosage calculated with ideal body weight reduce blood product use in open heart surgery?. Medicine Science, Cilt: 8 - Sayı: 1, 123–128. https://ajindex.com/articles/276960

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Finley A, Greenberg C. Review article: heparin sensitivity and resistance: management during cardiopulmonary bypass. Anesth Analg. 2013;116:121022. Jobes DR, Aitken GL, Shaffer GW. Increased accuracy and precision of heparin and protamine dosing reduces blood loss and transfusion in patients undergoing primary cardiac operations. J Thorac Cardiovasc Surg. 1995;110:36-45.
  2. Shuhaibar MN, Hargrove M, Millat MH, et al. How much heparin do we really need to go on pump? A rethink of current practices: European Journal of Cardio-thoracic Surgery. 2004:947-50. Goodman & Gilman’s The Pharmacological Basis of Therapeutics. 11th edition 2006 section 9-10, pp 1433-89
  3. Lobato RL, Despotis GJ, Levy JH, et al. Anticoagulation management during cardiopulmonary bypass: a survey of 54 North American institutions. J Thorac Cardiovasc Surg. 2010;139:1665-6.
  4. Levy JH, Sniecinski RM. Activated clotting times, heparin responses, and antithrombin: have we been wrong all these years? Anesth Analg. 2010;111:833-5.
  5. Doty DB, Knot HW, Hoyt JI, et al. Heparin dose for accurate anticoagulation in cardiac surgery. J Cardiovasc Surg. 1979;20:597-604.
  6. Bull BS, Huse WM, Brauer FS, et al. Heparin therapy during extracorporeal circulation. II. The use of a dose-response curve to individualize heparin and protamine dosage. J Thorac Cardiovasc Surg. 1975;69:685-9. Lorentz PDFH. Ein neuer Konstitutionsindex. Klin Wochenschr. 1929;8:34851. Schulman S, Bijsterveld NR. Anticoagulants and their reversal. Transfus Med Rev. 2007;21:37-48.
  7. Hirsh J, Warkentin TE, Shaughnessy SG, et al. Heparin and low-molecularweight heparin mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest J. 2001;119:64-94.
  8. Teoh K, Young E, Bradley C, et al. Heparin binding proteins. Contribution to heparin rebound after cardiopulmonary bypass. Circulation. 1993;88:420-5.
  9. Gravlee GP, Haddon WS, Rothberger HK, et al. Heparin dosing and monitoring for cardiopulmonary bypass. A comparison of techniques with measurement of subclinical plasma coagulation. J Thorac Cardiovasc Surg. 1990;99:518-27.
  10. Babka R, Colby C, El-Etr A, et al. Monitoring of intraoperative heparinization and blood loss following cardiopulmonary bypass surgery. J Thorac Cardiovasc Surg. 1977;73:780-2.
  11. Jobes DR, Aitken GL, Shaffer GW. Increased accuracy and precision of heparin and protamine dosing reduces blood loss and transfusion in patients undergoing primary cardiac operations. J Thorac Cardiovasc Surg. 1995;110:36-45.
  12. Runge M, Møll